BIOTECHNOLOGY REAGENTS AND KITS MARKET ANALYSIS

Market News

Global Biotechnology Reagents and Kits Market: Key Developments

• In May 2023, QIAGEN, a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, announced that it makes its high-quality enzymes available as individual products, providing researchers and industrial customers worldwide with the flexibility to customize their assays and workflows. This makes QIAGEN a one-stop shop for all research needs – from dedicated enzymes and sample preparation solutions to automation and bioinformatics solutions.
• In June 2022, altona Diagnostics GmbH, a medical diagnostic company launched the RealStar Zoonotic Orthopoxvirus PCR kit a real-time RT-PCR-based reagent system for the detection of zoonotic (non-variola) Orthopoxvirus species-specific DNA including monkeypox virus DNA of the Central and West African strains.
• In March 2021, QIAGEN introduced QIAcube Connect MDx to improve sample processing in diagnostic laboratories. This is an automated & flexible platform for sample processing and is now available globally

Global Biotechnology Reagents and Kits Market: Key Companies Insights

• The global biotechnology reagents and kits market is highly competitive. During the forecast period, the rapid developments in the biotechnology industry and growing biomolecular applications, are anticipated to fuel future growth.
• Some of the key players in the global biotechnology reagents and kits market are Thermo Fisher Scientific, Inc., QIAGEN, New England Biolabs, Illumina, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Takara Bio Inc.